The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

The vaccine will offer protection against H5N1 and is projected to be effective against future viral mutations.

Influenza significantly impacted adults aged 50 to 64 years and younger adults with chronic conditions, but risk can be reduced with RIV.

What the shingles vaccine does is it dampens reactivations of latent viruses in a way that may be protecting other parts of your body,” Martin said. Including, it seems, the brain. The measles, mumps ...

Infectious disease specialist Monica Gandhi, MD examines recent claims about the safety of thimerosal, a preservative used in some flu vaccines in the United States.

In a new consensus statement, the European Society of Cardiology has declared vaccinations for common infections to be a ...

More than 6 million Americans currently live with Alzheimer's disease, a number predicted to rise as our population ages.

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus challenges when combined with a mucosal adjuvant that enhances the body's ...

The vaccine panel hand-selected by health secretary and anti-vaccine advocate Robert F. Kennedy Jr. on Thursday voted ...

What we know about the safety, efficacy of mRNA vaccines amid recent scrutiny Vaccines using mRNA technology have been studied for decades, experts say.